| ID | 原文 | 译文 |
| 1583 | NS100mL+哌拉西林他唑巴坦 4.5g ivgtt q8h | NS100 mL + piperacillin/tazobactam 4.5 ivgtt q8h |
| 1584 | 肠内营养混悬液（白普力）500mL 鼻饲法 bid | Enteral nutrition suspension (Peptisorb liquid) 500 mL nasogastric feeding bid |
| 1585 | 国家卫生健康委国家中医药管理局《新型冠状病毒肺炎诊疗方案（试行第七版）》 | National Health Commission and National Administration of Traditional Chinese Medicine of the People's Republic of China. Protocols for Diagnosis and Treatment of COVID-19 (7th Trial Version) |
| 1586 | 国家卫生健康委《新型冠状病毒肺炎防控方案（第六版）》 | National Health Commission of the People's Republic of China. Protocols for Prevention and Control of COVID-19 (6th Version) |
| 1587 | 中国疾病预防控制中心《新型冠状病毒肺炎流行病学调查指南》 | Chinese Center for Disease Control and Prevention. Guidelines for Epidemiological Investigation of COVID-19 |
| 1588 | 中国疾病预防控制中心《新型冠状病毒肺炎病例密切接触者调查与管理指南》 | Chinese Center for Disease Control and Prevention. Guidelines for Investigation and Management of Close Contacts of COVID-19 Patients |
| 1589 | 中国疾病预防控制中心《新型冠状病毒肺炎实验室检测技术指南》 | Chinese Center for Disease Control and Prevention. Technical Guidelines for COVID-19 Laboratory Testing |
| 1590 | 中国疾病预防控制中心《特定场所消毒技术指南》 | Chinese Center for Disease Control and Prevention. Technical Guidelines for Disinfection of Special Sites |
| 1591 | 中国疾病预防控制中心《特定人群个人防护指南》 | Chinese Center for Disease Control and Prevention. Guidelines for Personal Protection of Specific Groups |
| 1592 | 浙江省市场监督管理局.新冠肺炎疫情防控技术指南第3部分：医疗机构：DB33/T 2241.1—2020 | Technical Guidelines for Prevention and Control of COVID-19, Part3: Medical Institutions, Local Standards of Zhejiang Province DB33/T 2241.3—2020 |